相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The intra-tumoral relationship between microcirculation, interstitial fluid pressure and liposome accumulation
Shawn Stapleton et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Spatial and temporal mapping of heterogeneity in liposome uptake and microvascular distribution in an orthotopic tumor xenograft model
Sandra N. Ekdawi et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Numerical modeling of drug delivery in a dynamic solid tumor microvasculature
M. Sefidgar et al.
MICROVASCULAR RESEARCH (2015)
Influence of vascular normalization on interstitial flow and delivery of liposomes in tumors
Deniz Ozturk et al.
PHYSICS IN MEDICINE AND BIOLOGY (2015)
Characterizing EPR-mediated passive drug targeting using contrast-enhanced functional ultrasound imaging
Benjamin Theek et al.
JOURNAL OF CONTROLLED RELEASE (2014)
The effect of interstitial pressure on therapeutic agent transport: Coupling with the tumor blood and lymphatic vascular systems
Min Wu et al.
JOURNAL OF THEORETICAL BIOLOGY (2014)
Distribution of the anticancer drugs doxorubicin, mitoxantrone and topotecan in tumors and normal tissues
Krupa J. Patel et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Coevolution of Solid Stress and Interstitial Fluid Pressure in Tumors During Progression: Implications for Vascular Collapse
Triantafyllos Stylianopoulos et al.
CANCER RESEARCH (2013)
Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers
Rakesh K. Jain
JOURNAL OF CLINICAL ONCOLOGY (2013)
The effect of interstitial pressure on tumor growth: Coupling with the blood and lymphatic vascular systems
Min Wu et al.
JOURNAL OF THEORETICAL BIOLOGY (2013)
A mathematical model for the effect of anti-angiogenic therapy in the treatment of cancer tumours by chemotherapy
S. T. R. Pinho et al.
NONLINEAR ANALYSIS-REAL WORLD APPLICATIONS (2013)
Numerical Modeling of Interstitial Fluid Flow Coupled with Blood Flow through a Remodeled Solid Tumor Microvascular Network
M. Soltani et al.
PLOS ONE (2013)
Interstitial Fluid Flow and Drug Delivery in Vascularized Tumors: A Computational Model
Michael Welter et al.
PLOS ONE (2013)
Combining two strategies to improve perfusion and drug delivery in solid tumors
Triantafyllos Stylianopoulos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
A new mathematical model for optimizing the combination between antiangiogenic and cytotoxic drugs in oncology
Sebastien Benzekry et al.
COMPTES RENDUS MATHEMATIQUE (2012)
Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner
Vikash P. Chauhan et al.
NATURE NANOTECHNOLOGY (2012)
TGF-β blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stroma
Jieqiong Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Vascular Normalization as a Therapeutic Strategy for Malignant and Nonmalignant Disease
Shom Goel et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Longitudinal Investigation of Permeability and Distribution of Macromolecules in Mouse Malignant Transformation Using PET
Cecilie B. Rygh et al.
CLINICAL CANCER RESEARCH (2011)
RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2-Negative, Locally Recurrent or Metastatic Breast Cancer
Nicholas J. Robert et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
H. Cabral et al.
NATURE NANOTECHNOLOGY (2011)
Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
Peter Carmeliet et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
A Phase 3 Trial of Bevacizumab in Ovarian Cancer
Timothy J. Perren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Delivery of Molecular and Nanoscale Medicine to Tumors: Transport Barriers and Strategies
Vikash P. Chauhan et al.
ANNUAL REVIEW OF CHEMICAL AND BIOMOLECULAR ENGINEERING, VOL 2 (2011)
Capecitabine, Bevacizumab, and Mitomycin in First-Line Treatment of Metastatic Colorectal Cancer: Results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study
Niall C. Tebbutt et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer
David W. Miles et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Effect of Pazopanib on Tumor Microenvironment and Liposome Delivery
Tina D. Tailor et al.
MOLECULAR CANCER THERAPEUTICS (2010)
In Vivo Distribution of Polymeric Nanoparticles at the Whole-Body, Tumor, and Cellular Levels
Helen Lee et al.
PHARMACEUTICAL RESEARCH (2010)
Study of tumor blood perfusion and its variation due to vascular normalization by anti-angiogenic therapy based on 3D angiogenic microvasculature
Jie Wu et al.
JOURNAL OF BIOMECHANICS (2009)
Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non-Small-Cell Lung Cancer: AVAiL
Martin Reck et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Independent Review of E2100: A Phase III Trial of Bevacizumab Plus Paclitaxel Versus Paclitaxel in Women With Metastatic Breast Cancer
Robert Gray et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
On optimal delivery of combination therapy for tumors
Alberto d'Onofrio et al.
MATHEMATICAL BIOSCIENCES (2009)
Tumor Vascular Permeability to a Nanoprobe Correlates to Tumor-Specific Expression Levels of Angiogenic Markers
Efstathios Karathanasis et al.
PLOS ONE (2009)
Interstitial fluid pressure in tumors: therapeutic barrier and biomarker of angiogenesis
Sarah Jane Lunt et al.
FUTURE ONCOLOGY (2008)
Optimal and suboptimal protocols for a class of mathematical models of tumor anti-angiogenesis
Urszula Ledzewicz et al.
JOURNAL OF THEORETICAL BIOLOGY (2008)
Combination of antiangiogenesis with chemotherapy for more effective cancer treatment
Jie Ma et al.
MOLECULAR CANCER THERAPEUTICS (2008)
A theoretical study of the response of vascular tumours to different types of chemotherapy
Jasmina Panovska et al.
MATHEMATICAL AND COMPUTER MODELLING (2008)
Tumor necrosis factor α mediates homogeneous distribution of liposomes in murine melanoma that contributes to a better tumor response
Ann L. B. Seynhaeve et al.
CANCER RESEARCH (2007)
Dynamics of tumor growth and combination of anti-angiogenic and cytotoxic therapies
M. Kohandel et al.
PHYSICS IN MEDICINE AND BIOLOGY (2007)
Effect of vascular normalization, by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: Insights from a mathematical model
Rakesh K. Jain et al.
CANCER RESEARCH (2007)
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients
Tracy T. Batchelor et al.
CANCER CELL (2007)
Tumor microvasculature and microenvironment: Targets for anti-angiogenesis and normalization
Dai Fukumura et al.
MICROVASCULAR RESEARCH (2007)
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer
Alan Sandler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A sensitive in vivo model for quantifying interstitial convective transport of injected macromolecules and nanoparticles
Sai T. Reddy et al.
JOURNAL OF APPLIED PHYSIOLOGY (2006)
Mathematical modelling of dynamic adaptive tumour-induced angiogenesis: Clinical implications and therapeutic targeting strategies
Steven R. McDougall et al.
JOURNAL OF THEORETICAL BIOLOGY (2006)
Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors
KM Laginha et al.
CLINICAL CANCER RESEARCH (2005)
Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system
S Sengupta et al.
NATURE (2005)
Repopulation of cancer cells during therapy: An important cause of treatment failure
JJ Kim et al.
NATURE REVIEWS CANCER (2005)
Mathematical modelling of flow in 2D and 3D vascular networks:: Applications to anti-angiogenic and chemotherapeutic drug strategies
A Stéphanou et al.
MATHEMATICAL AND COMPUTER MODELLING (2005)
Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy
RK Jain
SCIENCE (2005)
Lack of lymphangiogenesis during breast carcinogenesis
MM Vleugel et al.
JOURNAL OF CLINICAL PATHOLOGY (2004)
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
H Hurwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors
RT Tong et al.
CANCER RESEARCH (2004)
Intratumour heterogeneity in the uptake of macromolecular therapeutic agents in human melanoma xenografts
BA Graff et al.
BRITISH JOURNAL OF CANCER (2003)
Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU) leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer
F Kabbinavar et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Mathematical modelling of flow through vascular networks: Implications for ibmour-induced angiogenesis and chemotherapy strategies
SR McDougall et al.
BULLETIN OF MATHEMATICAL BIOLOGY (2002)
Simulation of the delivery of doxorubicin to hepatoma
YMF Goh et al.
PHARMACEUTICAL RESEARCH (2001)
Role of tumor-host interactions in interstitial diffusion of macromolecules: Cranial vs. subcutaneous tumors
A Pluen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
分享论文
